TrialAntimicrobial agents and chemotherapy2008

Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.

Jade Ghosn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.